Trade rumors involving ace pitcher Tarik Skubal have surged once more, dominating conversations across Major League Baseball this offseason period. As the Detroit Tigers navigate a challenging campaign, the possibility of dealing their star left-hander has gained fresh momentum amid ongoing uncertainties.
Skubal enters the final season of his current agreement, creating a high-stakes environment for both player and organization. During arbitration proceedings, the Tigers and Skubal’s representatives, headed by agent Scott Boras, presented sharply contrasting figures. Detroit proposed $19 million, falling $13 million short of the pitcher’s asking price.
In the end, Skubal secured victory in the hearing, with the panel approving his $32 million salary request for the 2026 season. This outcome reinforced widespread expectations that the two-time American League Cy Young Award winner would not remain with the Tigers beyond this year.
Given the clear differences in priorities and Skubal’s impending free agency, Detroit explored trade possibilities to maximize value. However, several complicating elements made an immediate deal complicated before the season began.
The expiring nature of Skubal’s contract meant any acquiring team needed to weigh seriously whether they could retain him long-term or accept the reality of a short-term rental at a premium cost. While many clubs lack the financial flexibility to meet Skubal’s future market demands, a select group stands ready to pursue such an elite talent.
Adding another layer, the Tigers held optimism about competing effectively in 2026. Following the arbitration result, they committed to free agent Framber Valdez on a three-year, $115 million contract. This acquisition served both as a contingency for Skubal’s potential exit and a bold step to strengthen their rotation with two premier left-handed starters.
Yet the season has unfolded differently than hoped. After a respectable beginning, Detroit has endured a sharp decline, dropping 14 of their last 16 contests and falling to a 20-31 record, placing them at the bottom of the AL Central standings.
Compounding the difficulties, Skubal recently underwent a procedure to remove a loose body from his left elbow, initially projected to sideline him for two to three months. Despite the setback, positive signs have emerged regarding his recovery.
Reports indicate Skubal is progressing faster than anticipated. He completed a multi-inning bullpen session on Thursday, reaching his velocity targets while displaying an upbeat demeanor.
MLB Insider Jon Heyman highlighted the shifting dynamics on Thursday, noting factors that are elevating the likelihood of a trade.
Should the Tigers decide to move Skubal, they confront a delicate balancing act. They must demonstrate his full health to potential suitors while managing the shrinking timeline, which reduces the control period any new team would receive before facing a substantial contract decision.
FanSided’s Robert Murray recently consulted several major league executives to gauge the current trade landscape for Skubal. Their perspectives reveal both interest and hesitation across the league.
One front office figure cited concerns over Skubal’s “bizarre injury” and Detroit’s competitive aspirations, estimating the cost at “one top-100 prospect plus a top-15 and one more throw in.” When asked if he would meet that asking price, the executive responded indirectly, stating, “The Padres will.”
A second executive singled out the San Diego Padres, along with Philadelphia Phillies president of baseball operations Dave Dombrowski, as among the few willing to surrender a top prospect. He observed that most organizations “[treat] it like Wall Street and asset value” and hesitate to invest heavily for limited guaranteed time.
This same source offered a bold forecast, suggesting the Los Angeles Dodgers and president Andrew Friedman could emerge as frontrunners. Such a move, he predicted, would further solidify the Dodgers as overwhelming World Series contenders.
The third executive emphasized risks tied to Skubal’s recent surgery but also addressed financial realities, explaining, “it’s tough for a team to just come up with the close to $12-14 million he will be owed after a trade that isn’t budgeted for.” He added that “if the Tigers pay down the salary the return could be better.”
As the situation develops, the Tigers find themselves in yet another complex predicament. Delaying action until midseason, combined with the injury, has already diminished potential returns. With each passing day during Skubal’s recovery, the available playing time for any acquiring club shrinks further, potentially softening the overall market value.
Detroit must now carefully weigh their remaining contention hopes against the opportunity to rebuild through a significant trade. The coming weeks promise to deliver more clarity on Skubal’s future and the franchise’s strategic direction.
